HOME
INDIA AT 2047
INDIA
WORLD
SPORTS
MOVIES
LIFESTYLE
TECHNOLOGY
SCIENCE
HEALTH
CRYPTO
MUTUAL FUNDS
PERSONAL FINANCE
OPINION
GAIL
IDEAS OF INDIA
UNCUT
WEB STORIES
EDUCATION
CRYPTO
BRAND WIRE
PODCAST
PHOTOS
GADGETS
WORLD
ELECTIONS
GAMING
AUTO
PIN CODE FINDER
LATEST MOBILE PHONES
IFSC CODE FINDER
CONTACT US
UTILITY
#
CDSCO
Paracetamol, Pan-D Among 53 Top-Selling Drugs Fail Quality Test By Indian Regulator
After WHO's Alert For India-Made Cough Syrups, CDSCO Initiates Probe: Report
Biological E Gets Govt Panel Nod To Manufacture 14-Valent Pneumococcal Conjugate Vaccine For Infants. All About It
SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
Covid Vaccine: Bharat Biotech Gets DCGI Permission For Intranasal Booster Dose Trials
Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval
‘False & Misleading’: Centre Dismisses Claims Of Expired COVID Vaccines Being Administered In India
Tags:
Bharat Biotech
Covishield
covaxin
Covid Vaccine: Health Ministry Gives Nod To Emergency Use Of Covovax, Corbevax & Molnupiravir Drug
Tags:
health ministry
Covid-19 vaccine
CDSCO
CDSCO Recommends Vaccine Corbevax & Anti-Covid Pill Molnupiravir With Caveat: Report
Tags:
Covid-19
Covid-19 vaccine
Central Drugs Standard Control Organisation
CDSCO Panel Recommends Emergency Use Authorisation For SII's Covid vaccine Covovax
Tags:
Covid-19
Covid-19 vaccine
serum institute of india
CDSCO Expert Panel Recommends Emergency Use Of Covaxin For Children Aged Between 2-18
Tags:
Bharat Biotech
DCGI
covaxin
Dr Reddy's To Collaborate With American Pharma Eli Lilly To Produce Baricitinib For Covid Treatment In India
Tags:
coronavirus
Ministry of Health
coronavirus treatment
Prev
1
Next